The WNBA has officially joined the growing list of professional sports leagues stepping away from cannabis prohibition. As part of its newly negotiated collective bargaining agreement — a seven-year deal running through 2032 — the league has agreed to eliminate marijuana testing for players. The move marks the end of an era in which women's basketball maintained one of the strictest cannabis policies in professional sports, and it signals a broader cultural shift that's rewriting the rulebook across American athletics.
What the WNBA Changed
Under the previous CBA, the WNBA conducted year-round testing for THC, the psychoactive compound in cannabis. Penalties escalated with each violation: first-time offenders faced mandatory treatment referrals, while repeat violations could result in suspensions and fines. The testing applied regardless of whether a player used cannabis during the season or the offseason, and regardless of whether she lived in a state where marijuana was legal.
Advertisement
The new agreement eliminates THC testing entirely. Players will no longer face urinalysis for cannabis, will not be penalized for positive THC results, and will not be required to enter treatment programs based on marijuana use alone. The league will continue testing for performance-enhancing drugs and substances of abuse other than cannabis.
The change didn't happen in a vacuum. It was one component of a broader CBA that includes significant economic gains for players — higher minimum salaries, improved travel accommodations, enhanced maternal benefits, and better revenue-sharing structures. But the cannabis provision carries symbolic weight that extends far beyond basketball.
The League-by-League Landscape in 2026
The WNBA's decision brings it into alignment with a trend that has swept through American professional sports over the past five years. Here's where every major league now stands.
The NBA led the way among the "Big Four" leagues. In its 2023 CBA, the league removed cannabis from its list of banned substances entirely. Players can use marijuana without restriction, and the league no longer tests for THC. Players are also permitted to invest in CBD and cannabis companies — a provision that would have been unthinkable a decade ago.
The NFL dramatically softened its stance in 2020, raising the THC testing threshold from 35 nanograms per milliliter to 150 ng/mL — a level so high that only heavy, recent use would trigger a positive. Testing is now limited to a two-week window during training camp, and first-time positives result in referral to a treatment program rather than suspension. The league eliminated game-day suspensions for cannabis entirely.
Major League Baseball removed cannabis from its banned substances list in 2019, following a series of minor league policy changes. Players are not tested for THC, though the league maintains a treatment-focused approach for players who seek help with substance use issues voluntarily.
The NHL has perhaps the most nuanced position. The league tests for cannabis but does not punish players for positive results. Instead, THC testing is used as part of the league's broader substance abuse and behavioral health program, with positive results triggering confidential outreach from program staff rather than discipline. No player has ever been suspended for marijuana use in NHL history.
Major League Soccer still tests for THC under its collective bargaining agreement, though penalties are relatively mild compared to the pre-2020 era. MLS remains the major outlier among top-tier American sports leagues.
Why the Shift Happened
The convergence of several forces made cannabis reform in sports inevitable. The most obvious is legalization itself. With 24 states permitting recreational use and 40 allowing medical marijuana, testing athletes for a substance that's legal where most of them live and play became increasingly untenable — both logistically and philosophically.
But the medical argument may have been even more persuasive in league negotiating rooms. Professional athletes subject their bodies to extraordinary physical punishment. NFL players sustain repeated traumatic brain injuries. NBA and WNBA players grind through 82-game seasons (or 40-game seasons, in the WNBA's case) with chronic joint and soft tissue stress. Baseball players face repetitive motion injuries that compound over 162-game campaigns.
Cannabis — particularly CBD-dominant products and balanced THC-CBD formulations — has emerged as a recovery tool that many athletes prefer to prescription painkillers. The opioid crisis cast a long shadow over professional sports, and leagues that once penalized players for using a relatively benign plant while their team doctors prescribed addictive opioids faced growing criticism for the hypocrisy.
Former athletes have been among the most vocal advocates. Retired NFL players have spoken publicly about using cannabis to manage chronic traumatic encephalopathy (CTE) symptoms, chronic pain, and the psychological toll of a career in violent contact sports. Their testimonials, combined with a growing body of research supporting cannabis's therapeutic applications, gave league officials and union negotiators the cover they needed to make policy changes.
Advertisement
The Athlete Wellness Reframe
Perhaps the most significant aspect of the WNBA's move — and the broader trend across sports — is the framing. Cannabis is no longer discussed primarily as a recreational drug that athletes use to get high. Instead, it's been repositioned within the wellness and recovery conversation.
This reframing matters because it shifts the moral calculus. When cannabis was framed as a vice, testing and punishment made intuitive sense to many fans and league officials. When it's framed as a recovery tool, comparable to ice baths, physical therapy, or anti-inflammatory medication, the same testing regime looks punitive and paternalistic.
The WNBA's new CBA reflects this philosophical shift explicitly. League communications around the agreement emphasize player wellbeing, quality of life, and the recognition that athletes are adults capable of making informed decisions about their own bodies.
What This Means for College Athletes
The professional leagues' evolution raises uncomfortable questions for college athletics, where cannabis policies remain significantly more restrictive. The NCAA still tests for THC, though it raised its threshold to 150 ng/mL in 2022 and no longer tests during championship events. Individual conferences and universities maintain their own policies, creating a patchwork of rules that can vary dramatically from school to school.
For college athletes preparing to enter professional leagues where cannabis is effectively permitted, the transition creates a strange contradiction: a substance that could end your college career won't even be tested for in the pros.
Reform advocates are pushing the NCAA to follow the professional leagues' lead, arguing that testing college athletes for marijuana — many of whom are over 21 and live in legal states — is both discriminatory (given the well-documented racial disparities in cannabis enforcement) and out of step with the cultural moment.
The Business Angle
The sports-cannabis convergence has business implications that extend beyond player contracts. With athletes now free to use and, in some cases, invest in cannabis products, the industry has gained a new class of high-profile ambassadors.
Several current and former NBA players have launched cannabis brands or invested in cannabis companies. The WNBA's policy change opens the door for women's basketball players to do the same — a development that cannabis companies focused on the growing female consumer market are watching closely.
Sponsorship dynamics are shifting as well. As cannabis companies gain legitimacy through Schedule III reclassification and banking reform, the possibility of cannabis brand sponsorships in professional sports — once utterly unthinkable — is inching closer to reality. While no major league has approved cannabis sponsorships yet, the conversation is underway.
Looking Ahead
The WNBA's decision to drop cannabis testing is less a revolution than a confirmation. The revolution happened gradually, over years of changing laws, evolving science, and shifting public opinion. By the time the WNBA acted, it was joining a consensus rather than leading one.
But that doesn't diminish the significance. Each league that updates its policy normalizes cannabis use in a context that millions of Americans pay attention to — sports. And as the last holdouts reconsider their positions, the day when cannabis testing in professional sports becomes a historical curiosity grows ever closer.
Related reading: Cannabis and athlete recovery — how pros use it · CBN, CBG, and THCV: minor cannabinoids for recovery and wellness · The DOJ's Schedule III order and what it means for cannabis normalization
Explore cannabis news, find dispensaries, and join the community at Budpedia.
Liked this? There's more every Friday.
The Budpedia Weekly: cannabis laws, science, deals, and strain reviews in your inbox.